These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26471861)

  • 21. Long-Term Stability and Clinical Utility of Amplified Atrial Electrograms in a Single-Lead ICD System with Floating Atrial Electrodes.
    Worden NE; Alqasrawi M; Mazur A
    Pacing Clin Electrophysiol; 2016 Dec; 39(12):1327-1334. PubMed ID: 27778352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA
    Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early ICD lead failure in defibrillator systems with multiple leads via cephalic access.
    Barbhaiya CR; Niazi O; Bostrom J; Patil S; Jankelson L; Bernstein S; Park D; Holmes D; Aizer A; Chinitz LA
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1462-1469. PubMed ID: 32356380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
    Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications.
    Ellenbogen KA; Wood MA; Shepard RK; Clemo HF; Vaughn T; Holloman K; Dow M; Leffler J; Abeyratne A; Verness D
    J Am Coll Cardiol; 2003 Jan; 41(1):73-80. PubMed ID: 12570948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate shocks in patients with Fidelis® lead fractures: impact of remote monitoring and the lead integrity algorithm.
    Blanck Z; Axtell K; Brodhagen K; O'Hearn L; Albelo T; Ceretto C; Dhala A; Sra J; Akhtar M
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1107-14. PubMed ID: 21539638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards eradication of inappropriate therapies for ICD lead failure by combining comprehensive remote monitoring and lead noise alerts.
    Ploux S; Swerdlow CD; Strik M; Welte N; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1125-1134. PubMed ID: 29858871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the performance of implantable cardioverter-defibrillator leads among manufacturers.
    Kondo Y; Nakano M; Kajiyama T; Nakano M; Hayashi T; Ito R; Takahira H; Kobayashi Y
    J Interv Card Electrophysiol; 2020 Aug; 58(2):133-139. PubMed ID: 31691064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term longevity and clinical outcomes of Linox S/SD implantable cardioverter-defibrillator leads: a single-center experience.
    Alasti M; Machado C; Mirzaee S; Healy S; Bittinger L; Adam D; Kotschet E; Krafchek J; Alison J
    J Interv Card Electrophysiol; 2021 Jun; 61(1):115-121. PubMed ID: 32488749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
    Sacher F; Probst V; Bessouet M; Wright M; Maluski A; Abbey S; Bordachar P; Deplagne A; Ploux S; Lande G; Jaïs P; Hocini M; Haïssaguerre M; Le Marec H; Clémenty J
    Europace; 2009 Apr; 11(4):489-94. PubMed ID: 19218576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multiple inappropriate defibrillator shocks due to insulation failure of a Biotronik Linox defibrillator lead with externalized conductor].
    Elfarra H; Moosdorf R; Rybinski L; Grimm W
    Herzschrittmacherther Elektrophysiol; 2016 Mar; 27(1):70-2. PubMed ID: 26848762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.